Display Page As Plain Text NASA Bioastronautics Roadmap SLSD JSC
Home | Missions | CC Areas | Disciplines | Risks | R & T Questions | Tasks | Deliverables | Processes | Search | Links | Help
Skip Risk List

Risks

   
 
  Current Selection Filters
 
 
 
 
All
 
 
Skip Risk/EQ/Task List
45 Risks found.
1 Accelerated Bone Loss and Fracture Risk
2 Impaired Fracture Healing
3 Injury to Joints and Intervertebral Structures
4 Renal Stone Formation
5 Occurrence of Serious Cardiac Dysrhythmias
6 Diminished Cardiac and Vascular Function
7 Define Acceptable Limits for Contaminants in Air and Water
8 Immune Dysfunction, Allergies and Autoimmunity
9 Interaction of Space flight Factors, Infections and Malignancy
10 Alterations in Microbes and Host Interactions
12345Next
   
Risk 5: Occurrence of Serious Cardiac Dysrhythmias  

 
 
Crosscutting Area : Human Health and Countermeasures
 
jump to contentDiscipline : Cardiovascular Alterations
 
Description : Serious cardiac dysrhythmias may occur due to prolonged exposure to hypogravity or asymptomatic cardiac disease.
 
Context / Risk Factors : Other physiological changes, such as altered neural and hormonal regulation, diminished cardiac mass and cardiac remodeling, and fluid and electrolyte alterations, may affect occurence of dysrhythmias. Flight duration, gender, and pre-existing cardiovascular disease are also risk factors.
 
Justification / Rationale : Cardiac rhythm disturbances have been observed on several occasions during space flight but the occurrence of space flight induced arrhythmias has not been documented. Recent flight and ground-based data demonstrate alterations in cardiac electrical activity, which may indicate altered cardiac electrical stability. If space flight increases the risk of serious cardiac dysrhythmias this could lead to syncope and/or death posing risk both to crewmembers and to the mission.
 
Reference Missions :
 
Skip Mission Links
ISS Lunar Mars
 
 
  Risk Rating
Priority 2
 
  Current Countermeasures
  • Resuscitation equipment, including onboard defibrillator
  • Crew medical screening
  • Onboard monitoring
 
  Projected Countermeasures or Mitigations and Other Deliverables with their CRL/TRL scores
  • Electrical cardioversion (Equipment currently on board, efficacy not demonstrated in space environment) [CRL 1]
  • Nutritional countermeasure [CRL 2]
  • Pharmaceutical countermeasure [CRL 1]
  • Pre-flight and in-flight testing and monitoring to assess altered susceptibility to dysrhythmias [CRL 7]
 
  Research & Technology Questions Skip EQ List
No.
Sorted in Ascending Order
Question Priority
5a Does space flight increase susceptibility to serious cardiac dysrhythmias? 1
5b What conditions of space flight (e.g., microgravity, disruption of physiological rhythms, nutrition, environmental factors and radiation) may be responsible for cardiac dysrhythmias, and what are the mechanisms involved? 1
5c Can risk of serious cardiac dysrhythmias be predicted for individual crewmembers? 1
5d What countermeasures may prevent or reduce the occurrence of serious cardiac dysrhythmias during long-term space flight? 1
5e Can susceptibility to, and occurrence of, serious cardiac dysrhythmias be effectively diagnosed and treated during space flight? 1
5f Which cardiovascular diseases are likely to be aggravated by space flight, and what mechanisms are involved? 1
5g What screening methods on the ground and in-flight might identify crewmembers with underlying cardiovascular disease, which may be aggravated by space flight? 1
 
  Related Risks
Cardiovascular Alterations
Diminished Cardiac and Vascular Function
Environmental Health
Define Acceptable Limits for Contaminants in Air and Water
Skeletal Muscle Alterations
Reduced Muscle Mass, Strength, and Endurance
Increased Susceptibility to Muscle Damage
Nutrition
Inadequate Nutrition
Clinical Capabilities
Monitoring and Prevention
Major Illness and Trauma
Pharmacology of Space Medicine Delivery
Ambulatory Care
Rehabilitation on Mars
Radiation
Acute and Late CNS Risks
Chronic and Degenerative Tissue Risks
Acute Radiation Risks
 
  Important References
Fritsch-Yelle JM, Leuenberger UA, D'Aunno DS, Rossum AC, Brown TE, Wood ML, Josephson ME, Goldberger AL. An Episode of Ventricular Tachycardia During Long-Duration Spaceflight. The American Journal of Cardiology. 1998 June;81: 1391-1392.
Smith RF, Stanton K, Stoop D, Brown D, Januez W, King P. Vectorcardiographic Changes During Extended Space flight (M093): Observations at Rest and During Exercise. In: Biomedical Results of Skylab (NASA SP-377). Johnston RS and Dietlein LF, editors. Washington, DC: NASA 339-350, 1977.
Rossum AC, Wood ML, Bishop Sl, Deblcok H, Charles JB. Evaluation of Cardiac Rhythym Disturbances During Extravehicular Activity. The American Journal of Cardiology. 1997 April;79: 1153-1155.
Charles JB, Bungo MW, Fortner GW. Cardiopulmonary Function. In: Nicogossian A, Huntoon C, Pool S, and (editors). Space Physiology and Medicine. 3rd ed. Philadelphia, PA: Lea & Febiger, 286-304, 1994.
 
NASA
Page Last Updated:  February 12, 2008
Page Editor:  Stuart S. Engelhardt Content Manager:  John B. Charles NASA Official:  John B. Charles Budgets, Strategic Plans, and Accountability Reports Equal Employment Opportunity Data Posted Pursuant to the No Fear Act Information-Dissemination Policies and Inventories Freedom of Information Act President's Management Agenda Privacy Policy & Important Notices Inspector General Hotline Contact SLSD Space Life Sciences Directorate Johnson Space Center USA.gov ExpectMore.gov